2024 Q3 Form 10-Q Financial Statement

#000143774924026572 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $11.81M
YoY Change 16.45%
Cost Of Revenue $6.307M
YoY Change 6.52%
Gross Profit $5.501M
YoY Change 30.39%
Gross Profit Margin 46.59%
Selling, General & Admin $2.712M
YoY Change 27.98%
% of Gross Profit 49.3%
Research & Development $682.0K
YoY Change 27.48%
% of Gross Profit 12.4%
Depreciation & Amortization $220.0K
YoY Change 7.84%
% of Gross Profit 4.0%
Operating Expenses $682.0K
YoY Change -74.3%
Operating Profit $2.107M
YoY Change 34.63%
Interest Expense $44.00K
YoY Change -980.0%
% of Operating Profit 2.09%
Other Income/Expense, Net $39.00K
YoY Change 129.41%
Pretax Income $2.146M
YoY Change 35.65%
Income Tax $402.0K
% Of Pretax Income 18.73%
Net Earnings $1.744M
YoY Change 36.57%
Net Earnings / Revenue 14.77%
Basic Earnings Per Share $0.64
Diluted Earnings Per Share $0.63
COMMON SHARES
Basic Shares Outstanding 2.809M 2.799M
Diluted Shares Outstanding 2.780M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.501M
YoY Change 392.13%
Cash & Equivalents $6.501M
Short-Term Investments
Other Short-Term Assets $640.0K
YoY Change 95.72%
Inventory $9.341M
Prepaid Expenses
Receivables $5.180M
Other Receivables $0.00
Total Short-Term Assets $21.66M
YoY Change 34.5%
LONG-TERM ASSETS
Property, Plant & Equipment $4.687M
YoY Change 31.51%
Goodwill $40.00K
YoY Change
Intangibles $40.00K
YoY Change -43.66%
Long-Term Investments
YoY Change
Other Assets $7.000K
YoY Change -46.15%
Total Long-Term Assets $6.720M
YoY Change 40.32%
TOTAL ASSETS
Total Short-Term Assets $21.66M
Total Long-Term Assets $6.720M
Total Assets $28.38M
YoY Change 35.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.442M
YoY Change -20.38%
Accrued Expenses $3.271M
YoY Change 41.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.713M
YoY Change -1.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $9.000K
YoY Change -78.57%
Total Long-Term Liabilities $9.000K
YoY Change -78.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.713M
Total Long-Term Liabilities $9.000K
Total Liabilities $4.722M
YoY Change -1.91%
SHAREHOLDERS EQUITY
Retained Earnings $6.931M
YoY Change 239.42%
Common Stock $16.73M
YoY Change 19.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.66M
YoY Change
Total Liabilities & Shareholders Equity $28.38M
YoY Change 35.83%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $1.744M
YoY Change 36.57%
Depreciation, Depletion And Amortization $220.0K
YoY Change 7.84%
Cash From Operating Activities $1.960M
YoY Change 292.0%
INVESTING ACTIVITIES
Capital Expenditures $873.0K
YoY Change 289.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$873.0K
YoY Change 289.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 1.960M
Cash From Investing Activities -873.0K
Cash From Financing Activities 0.000
Net Change In Cash 1.087M
YoY Change 460.31%
FREE CASH FLOW
Cash From Operating Activities $1.960M
Capital Expenditures $873.0K
Free Cash Flow $1.087M
YoY Change 293.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
M-tron Industries, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001902314
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
163000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
141000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2808579
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2808579
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2786321
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2786321
mpti Investment Expense Rate
InvestmentExpenseRate
0.0008 pure
CY2024Q2 us-gaap Payment For Management Fee
PaymentForManagementFee
0 usd
us-gaap Payment For Management Fee
PaymentForManagementFee
0 usd
CY2024Q2 us-gaap Assets Under Management Carrying Amount
AssetsUnderManagementCarryingAmount
0 usd
CY2022Q2 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41391
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0457944
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 Shader Rd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32804
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
298-2000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
dei Trading Symbol
TradingSymbol
MPTI
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2808579
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11808000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10140000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22993000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19507000 usd
CY2024Q2 us-gaap Manufacturing Costs
ManufacturingCosts
6307000 usd
CY2023Q2 us-gaap Manufacturing Costs
ManufacturingCosts
5921000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
12713000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
12092000 usd
CY2024Q2 mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
3394000 usd
CY2023Q2 mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
2654000 usd
mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
6384000 usd
mpti Engineering Selling And Administrative
EngineeringSellingAndAdministrative
5089000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
9701000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
8575000 usd
us-gaap Costs And Expenses
CostsAndExpenses
19097000 usd
us-gaap Costs And Expenses
CostsAndExpenses
17181000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2107000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1565000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3896000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2326000 usd
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
44000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
76000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
39000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
113000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2146000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1582000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4009000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2301000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
402000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
305000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
779000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
471000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1744000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1277000 usd
us-gaap Net Income Loss
NetIncomeLoss
3230000 usd
us-gaap Net Income Loss
NetIncomeLoss
1830000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2728599
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2697696
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2723293
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2688065
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2779802
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2711266
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2783739
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2709578
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6501000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3913000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5180000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4802000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
9341000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
8884000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
640000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
588000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
21662000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
18187000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4687000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4131000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
97000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
45000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1943000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1835000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000 usd
CY2024Q2 us-gaap Assets
Assets
28382000 usd
CY2023Q4 us-gaap Assets
Assets
24305000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1442000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1300000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2286000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2196000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
985000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
611000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
277000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4713000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4384000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
4722000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4410000 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
27000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16702000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16167000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6931000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3701000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23660000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19895000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28382000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24305000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
21715000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1744000 usd
CY2024Q2 mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
0 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
201000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23660000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14746000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1277000 usd
CY2023Q2 mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
140000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16081000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19895000 usd
us-gaap Net Income Loss
NetIncomeLoss
3230000 usd
mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
408000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
127000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23660000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14341000 usd
us-gaap Net Income Loss
NetIncomeLoss
1830000 usd
mpti Adjustments To Additional Paid In Capital Transfers To Former Parent
AdjustmentsToAdditionalPaidInCapitalTransfersToFormerParent
-219000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
211000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16081000 usd
us-gaap Net Income Loss
NetIncomeLoss
3230000 usd
us-gaap Net Income Loss
NetIncomeLoss
1830000 usd
us-gaap Depreciation
Depreciation
439000 usd
us-gaap Depreciation
Depreciation
385000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
408000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
211000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-108000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
378000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
548000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
457000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1195000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-349000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
366000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-300000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
226000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1051000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3456000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
779000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
995000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
302000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-995000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-302000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
82000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
127000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
127000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-82000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2588000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
395000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3913000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
926000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6501000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1321000 usd
us-gaap Interest Paid Net
InterestPaidNet
5000 usd
us-gaap Interest Paid Net
InterestPaidNet
7000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1275000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p>
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
682000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1315000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
535000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1064000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Concentration Risks</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2024</em>, the Company's largest and <em style="font: inherit;">second</em> largest customers accounted for $4,452, or 37.7%, and $2,216, or 18.8%, of the Company's Revenues, respectively. For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023</em>, the Company's largest and <em style="font: inherit;">second</em> largest customers accounted for $2,723, or 26.9%, and $1,662, or 16.4%, of the Company’s Revenues, respectively.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2024</em>, the Company's largest and <em style="font: inherit;">second</em> largest customers accounted for $9,327, or 40.6%, and $4,419, or 19.2%, of the Company's Revenues, respectively. For the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023</em>, the Company's largest and <em style="font: inherit;">second</em> largest customers accounted for $5,057, or 25.9%, and $2,671, or 13.7%, of the Company's Revenues, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">A significant portion of the Company's accounts receivable is concentrated with a relatively small number of customers. As of <em style="font: inherit;"> June 30, 2024</em>, the Company's <span style="-sec-ix-hidden:c116309268">four</span> largest customers accounted for approximately $2,972, or 55.6%, of gross accounts receivable. As of <em style="font: inherit;"> December 31, 2023</em>, <span style="-sec-ix-hidden:c116309271">four</span> of the Company's largest customers accounted for approximately $3,774, or 76.4%, of gross accounts receivable. The Company carefully evaluates the creditworthiness of its customers in deciding to extend credit. As a result, the Company has experienced very low historical bad debt expense and believes the related risk to be minimal.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2 mpti Investment Expense Rate
InvestmentExpenseRate
0.0008 pure
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.187 pure
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.194 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205 pure
CY2024Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1744000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1277000 usd
us-gaap Net Income Loss
NetIncomeLoss
3230000 usd
us-gaap Net Income Loss
NetIncomeLoss
1830000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2728599
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2697696
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2723293
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2688065
CY2024Q2 mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
CY2023Q2 mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
107
mpti Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
CY2024Q2 mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
51203
CY2023Q2 mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
13570
mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
60339
mpti Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
21513
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2779802
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2711266
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2783739
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2709578
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4504000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4368000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4484000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4150000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1756000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1634000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
10744000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
10152000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1403000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1268000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
9341000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
8884000 usd
CY2024Q2 us-gaap Land
Land
536000 usd
CY2023Q4 us-gaap Land
Land
536000 usd
CY2024Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5321000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5216000 usd
CY2024Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
20936000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
20046000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26793000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25798000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22106000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21667000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4687000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4131000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
40000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
40000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1266000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1266000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1226000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1221000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45000 usd

Files In Submission

Name View Source Status
0001437749-24-026572-index-headers.html Edgar Link pending
0001437749-24-026572-index.html Edgar Link pending
0001437749-24-026572.txt Edgar Link pending
0001437749-24-026572-xbrl.zip Edgar Link pending
ex_673946.htm Edgar Link pending
ex_673947.htm Edgar Link pending
ex_673948.htm Edgar Link pending
ex_673949.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpti-20240630.xsd Edgar Link pending
mpti20240813_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mpti-20240630_cal.xml Edgar Link unprocessable
mpti-20240630_def.xml Edgar Link unprocessable
mpti-20240630_pre.xml Edgar Link unprocessable
mpti20240813_10q_htm.xml Edgar Link completed
mtronlogosmall.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mpti-20240630_lab.xml Edgar Link unprocessable